The Tumor Immune Microenvironment in Cutaneous Squamous Cell Carcinoma Arising in Organ Transplant Recipients

키워드

참고문헌 (55)

1. Hartevelt MM, "Incidence of skin cancer after renal transplantation in The Netherlands", Transplantation, 49, pp.506~509 (1990)
2. Krynitz B, "Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008 : a Swedish population-based study", Int J Cancer, 132, pp.1429~1438 (2013)
3. Moloney FJ, "A population-based study of skin cancer incidence and prevalence in renal transplant recipients", Br J Dermatol, 154, pp.498~504 (2006)
4. Wehner MR, "Risks of multiple skin cancers in organ transplant recipients : a cohort study in 2 administrative data sets", JAMA Dermatol, 157, pp.1447~1455 (2021)
5. Bouwes Bavinck JN, "Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients : a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy", J Invest Dermatol, 127, pp.1647~1656 (2007)
6. Rashtak S, "Incidence and risk factors for skin cancer following lung transplantation", J Am Acad Dermatol, 72, pp.92~98 (2015)
7. Lott DG, "Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients", Transplantation, 90, pp.683~687 (2010)
8. Mittal A, "Skin cancers in organ transplant recipients", Am J Transplant, 17, pp.2509~2530 (2017)
9. Ritter A, "Solid organ transplantation worsens the prognosis of patients with cutaneous squamous cell carcinoma of the head and neck region-Comparison between solid organ transplant recipients and immunocompetent patients", Head Neck, 43, pp.884~894 (2021)
10. Jiyad Z, "Azathioprine and risk of skin cancer in organ transplant recipients : systematic review and meta-analysis", Am J Transplant, 16, pp.3490~3503 (2016)
11. Coghill AE, "Immunosuppressive medications and squamous cell skin carcinoma : nested case-control study within the skin cancer after organ transplant(SCOT)cohort", Am J Transplant, 16, pp.565~573 (2016)
12. Genders RE, "Metastasis of cutaneous squamous cell carcinoma in organ transplant recipients and the immunocompetent population: is there a difference? A systematic review and meta-analysis", J Eur Acad Dermatol Venereol, 33, pp.828~841 (2019)
13. Tuong ZK, "Cytokine", chemokine profiles in squamous cell carcinoma correlate with precancerous and cancerous disease stage, 2019, pp.9, 17754~
14. Hussein MR, "Analysis of the mononuclear inflammatory cell infiltrate in the non-tumorigenic, pre-tumorigenic and tumorigenic keratinocytic hyperproliferative lesions of the skin", Cancer Biol Ther, 4, pp.819~821 (2005)
15. Mühleisen B, "Progression of cutaneous squamous cell carcinoma in immunosuppressed patients is associated with reduced CD123+ and FOXP3+ cells in the perineoplastic inflammatory infiltrate", Histopathology, 55, pp.67~76 (2009)
16. Strobel SB, "Altered density, composition and microanatomical distribution of infiltrating immune cells in cutaneous squamous cell carcinoma of organ transplant recipients", Br J Dermatol, 179, pp.405~412 (2018)
17. Klebanoff CA, "Central memory self", tumor-reactive CD8+T cells confer superior antitumor immunity compared with effector memory T cells, 2005, pp.102, 9571~9576
18. Ali HR, "Association between CD8+ T-cell infiltration and breast cancer survival in 12, 439 patients", Ann Oncol, 25, pp.1536~1543 (2014)
19. Kawai O, "Predominant infiltration of macrophages and CD8(+)T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer", Cancer, 113, pp.1387~1395 (2008)
20. Frazzette N, "Decreased cytotoxic T cells and TCR clonality in organ transplant recipients with squamous cell carcinoma", NPJ Precis Oncol, 4, pp.13~ (2020)
21. Zhang S, "Increased Tc22 and Treg", CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma, 2013, pp.8, e62154~
22. Datta RR, "Post-transplant malignancies show reduced T-cell abundance and tertiary lymphoid structures as correlates of impaired cancer immunosurveillance", Clin Cancer Res, 28, pp.1712~1723 (2022)
23. Chaput N, "Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue", Gut, 58, pp.520~529 (2009)
24. Clark RA, "Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells", J Exp Med, 205, pp.2221~2234 (2008)
25. Kosmidis M, "Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients", J Immunother, 33, pp.538~546 (2010)
26. Glaun M, "The tumor microenvironment of cutaneous squamous cell carcinoma in immunosuppressed patients", Research Square (2021)[DOI]
27. Freeman A, "Comparative immune phenotypic analysis of cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in immune-competent individuals : proportional representation of CD8+ T-cells but not FoxP3+ regulatory T-cells is associated with disease stage", PLoS One, 9, pp.e110928~ (2014)
28. Shang B, "Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers : a systematic review and meta-analysis", Sci Rep, 5, pp.15179~ (2015)
29. Lai C, "OX40+ regulatory T cells in cutaneous squamous cell carcinoma suppress effector T-cell responses and associate with metastatic potential", Clin Cancer Res, 22, pp.4236~4248 (2016)
30. Feldmeyer L, "Differential T-cell subset representation in cutaneous squamous cell carcinoma arising in immunosuppressed versus immunocompetent individuals", Exp Dermatol, 25, pp.245~247 (2016)
31. Veglia F, "Myeloid-derived suppressor cells coming of age", Nat Immunol, 19, pp.108~119 (2018)
32. Ai L, "Prognostic role of myeloid-derived suppressor cells in cancers : a systematic review and meta-analysis", BMC Cancer, 18, pp.1220~ (2018)
33. Seddon A, "Cutaneous squamous cell carcinomas with markers of increased metastatic risk are associated with elevated numbers of neutrophils and", or granulocytic myeloid derived suppressor cells, 2016, pp.83, 124~130
34. Pan Y, "Tumor-associated macrophages in tumor immunity", Front Immunol, 11, pp.583084~ (2020)
35. Cyrus N, "Density and polarization states of tumor-associated macrophages in human cutaneous squamous cell carcinomas arising in solid organ transplant recipients", Dermatol Surg, 42(Suppl 1), pp.S18~S23 (2016)
36. Yanofsky VR, "Understanding dendritic cells and their role in cutaneous carcinoma and cancer immunotherapy", Clin Dev Immunol, 2013, pp.624123~ (2013)
37. Gibson GE, "Langerhans cells in benign, premalignant and malignant skin lesions of renal transplant recipients and the effect of retinoid therapy", J Eur Acad Dermatol Venereol, 10, pp.130~136 (1998)
38. Sandvik LF, "Peritumoral dermis of squamous cell carcinomas in renal transplant recipients contains less CD11c+ myeloid dendritic cells and FoxP3+ T cells compared to immunocompetent controls", J Eur Acad Dermatol Venereol, 29, pp.2128~2135 (2015)
39. Dias de Oliveira NF, "Plasmacytoid dendritic cells in dermatology", An Bras Dermatol, 96, pp.76~81 (2021)
40. Wawrzycki B, "Interleukin-22 and its correlation with disease activity in plaque psoriasis", Arch Immunol Ther Exp(Warsz), 67, pp.103~108 (2019)
41. Commandeur S, "Functional characterization of cancer-associated fibroblasts of human cutaneous squamous cell carcinoma", Exp Dermatol, 20, pp.737~742 (2011)
42. Slater NA, "PD-L1 expression in cutaneous squamous cell carcinoma correlates with risk of metastasis", J Cutan Pathol, 43, pp.663~670 (2016)
43. Varki V, "PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma", Cancer Immunol Immunother, 67, pp.805~814 (2018)
44. Stevenson ML, "Expression of programmed cell death ligand in cutaneous squamous cell carcinoma and treatment of locally advanced disease with pembrolizumab", JAMA Dermatol, 153, pp.299~303 (2017)
45. Amoils M, "PDL1expression and tumor-infiltrating lymphocytes in high-risk and metastatic cutaneous squamous cell carcinoma", Otolaryngol Head Neck Surg, 160, pp.93~99 (2019)
46. Croft M, "The significance of OX40and OX40L to T-cell biology and immune disease", Immunol Rev, 229, pp.173~191 (2009)
47. Maruhashi T, "LAG-3 : from molecular functions to clinical applications", J Immunother Cancer, 8, pp.e001014~ (2020)
48. Durham NM, "Lymphocyte Activation Gene 3(LAG-3)modulates the ability of CD4 T-cells to be suppressed in vivo", PLoS One, 9, pp.e109080~ (2014)
49. Wu S, "PD-L1 and LAG-3 expression in advanced cutaneous squamous cell carcinomas", J Cutan Pathol, 47, pp.882~887 (2020)
50. Portuguese AJ, "Immune checkpoint inhibitor use in solid organ transplant recipients : a systematic review", J Natl Compr Canc Netw, 20, pp.406~416 (2022)
51. Choudhary NS, "Acute and chronic rejection after liver transplantation : what a clinician needs to know", J Clin Exp Hepatol, 7, pp.358~366 (2017)
52. ANZDATA 43rd annual report 2020, "ANZDATA Registry", ANZDATA Registry, ~ (2020)
53. Murakami N, "A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant", Kidney Int, 100, pp.196~205 (2021)
54. Tsung I, "A pilot study of checkpoint inhibitors in solid organ transplant recipients with metastatic cutaneous squamous cell carcinoma", Oncologist, 26, pp.133~138 (2021)
55. Rana A, "Outcomes in solid-organ transplantation : success and stagnation", Tex Heart Inst J, 46, pp.75~76 (2019)

관련 논문AI추천